Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2/PHASE3
103 participants
INTERVENTIONAL
2005-07-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Near Infrared Spectroscopy (NIRS)
NCT01429324
Infrared Imaging in Septic Illness
NCT02855671
Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia
NCT03024021
Accuracy of Zero Heat Flux Cutaneous Temperature in Intensive Care Adults
NCT02931227
Accuracy of Infrared Thermography for Detecting Febrile Critically Ill Patients
NCT04571554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, the assessment of tissue oxygenation and perfusion is recommended in patients with severe sepsis.
The InSpectra tissue spectrometer relies on continuous wave near infrared (NIR) technology to estimate non invasively local tissue hemoglobin oxygen saturation in tissue (% StO2). This technology had been tested in a variety of systems: standard theoretical models of light transport, isolated blood, isolated blood-perfused animal organs and healthy human volunteers with induced limb ischemia. In critical-care medicine, NIRS has also been used to evaluate muscle oxygenation in trauma resuscitation and in lower extremity and abdominal compartment syndrome. However, NIRS has been rarely utilised to measure tissue blood flow and oxygen uptake in critically ill patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Early goal directed therapy based on StO2 evaluation
Near Infrared Spectroscopy
resuscitation will be based on Surviving Sepsis Campaign guidelines AND on increasing StO2 to 80% or more in at least 2 out of the 3 following sites: thenar, masseter and deltoid
2
Early goal directed therapy
conventional
resuscitation will be based according to Surviving Sepsis Campaign
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Near Infrared Spectroscopy
resuscitation will be based on Surviving Sepsis Campaign guidelines AND on increasing StO2 to 80% or more in at least 2 out of the 3 following sites: thenar, masseter and deltoid
conventional
resuscitation will be based according to Surviving Sepsis Campaign
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* systolic blood pressure =\< 90 mm Hg; or
* a blood lactate concentration =\> 4 mmol/l; or
* skin marbling; or
* impaired consciousness; or
* urine output \< 30 ml/h.
Exclusion Criteria
* Pregnancy
* Do-not-resuscitate status
* Advanced directives restricting implementation of the protocol
* Obesity (body mass index \[BMI\] \> 30)
* Anasarca
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hutchinson Technology Inc
INDUSTRY
Assistance Publique - Hôpitaux de Paris
OTHER
University of Versailles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Djillali Annane
Professor in medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Djillali Annane, MD, PhD
Role: STUDY_CHAIR
Raymond Poincaré Hospital, AP-HP
Olivier Nardi, MD
Role: STUDY_DIRECTOR
Raymond Poincaré Hospital, AP-HP
Gwenhael Colin, MD
Role: PRINCIPAL_INVESTIGATOR
Raymond Poincaré Hospital, AP-HP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Raymond Poincaré Hospital
Garches, , France
Hôpital Nord AP HM
Marseille, , France
CHU Tours
Tours, , France
GERLACH Herwig
Berlin, , Germany
University Hospital Rostock
Rostock, , Germany
NANAS Serafeim
Athens, , Greece
EZAVALA Elizabeth
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nardi O, Zavala E, Martin C, Nanas S, Scheeren T, Polito A, Borrat X, Annane D. Targeting skeletal muscle tissue oxygenation (StO2) in adults with severe sepsis and septic shock: a randomised controlled trial (OTO-StS Study). BMJ Open. 2018 Mar 19;8(3):e017581. doi: 10.1136/bmjopen-2017-017581.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.